Browsing Tag
Kahn Swick & Foti
4 posts
BioSig Technologies faces shareholder scrutiny over Streamex merger terms
BioSig's merger with Streamex Exchange cuts shareholder stake to 25%—find out why legal experts and investors are raising red flags.
Why NET Power faces a class action lawsuit over Project Permian cost overruns and delays
NET Power shareholders face a June 17 deadline to join a class action lawsuit over $2B Project Permian costs and a 2029 delay. Learn what’s at stake.
Why Iovance Biotherapeutics faces a class action lawsuit after a 45% stock crash
Iovance faces a class action lawsuit after cutting 2025 revenue guidance by 40%. Learn what triggered the stock’s 45% drop and how investors can file claims.
Red Cat Holdings Lawsuit puts defense drone valuations under spotlight amid investor turmoil
RCAT stock dropped 21% after fraud allegations tied to a U.S. Army contract. Learn what’s next for investors ahead of the July 22, 2025, class action deadline.